269 filings
8-K
TXMD
TherapeuticsMD Inc
10 May 24
TherapeuticsMD Announces First Quarter 2024 Financial Results
4:15pm
8-K
TXMD
TherapeuticsMD Inc
29 Mar 24
TherapeuticsMD Announces Full Year 2023 Financial Results
4:29pm
8-K
TXMD
TherapeuticsMD Inc
14 Nov 23
TherapeuticsMD Announces Third Quarter 2023 Financial Results
4:25pm
8-K
TXMD
TherapeuticsMD Inc
18 Aug 23
Entry into a Material Definitive Agreement
5:18pm
8-K
TXMD
TherapeuticsMD Inc
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am
8-K
r7iszm5f4zwns7gd1qnh
10 Jul 23
Changes in Registrant's Certifying Accountant
5:20pm
8-K
crq3z emfzs
6 Jul 23
Unregistered Sales of Equity Securities
4:38pm
8-K
5ei2gw79pjhs2kupt9
28 Jun 23
Submission of Matters to a Vote of Security Holders
7:00am
8-K
0zryxj4
15 May 23
TherapeuticsMD Announces First Quarter 2023 Financial Results
4:16pm
8-K
cjp ho3wwrk8l37d
5 May 23
Entry into a Material Definitive Agreement
5:26pm
8-K
yqz6wf9dn5au8
21 Apr 23
Other Events
5:14pm
8-K
j4u0u4pjgz
7 Apr 23
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
4:41pm
8-K
pz24rq f7o69t
27 Feb 23
Departure of Directors or Certain Officers
4:27pm
8-K
byy9g6wbharun1ebni
18 Jan 23
Departure of Directors or Certain Officers
5:00pm
8-K
sq4gdpp9
12 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K/A
n3sdvi
6 Jan 23
Departure of Directors or Certain Officers
5:30pm
8-K
i5e 3pw3j0776hxdb
3 Jan 23
TherapeuticsMD Completes Transaction to License its Products to Mayne Pharma
7:00am
8-K
mjgqr434zr3v8d2sm1
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
1jnijuzla
1 Dec 22
Entry into a Material Definitive Agreement
9:23am
8-K
dnh6t kaz9prm6
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm